Maynard Ryan D
CIK: 0001363984•CHIEF FINANCIAL OFFICER
Officer
Primary company: RIGEL PHARMACEUTICALS INC (RIGL)
Maynard Ryan D is a corporate insider (CHIEF FINANCIAL OFFICER) at RIGEL PHARMACEUTICALS INC (RIGL) filing SEC Form 4 transactions. 59 transactions across 3 companies, totaling $50,588 in purchases and $1,955,957 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 90,316 | - | - | 90,316 | 6/16/2026 Filed: 6/16/2026 | Filing → | |
| Award | 67,546 | - | - | 67,546 | 6/13/2025 Filed: 6/17/2025 | Filing → | |
| Exercise | 50,000 | - | - | 0 | 11/12/2024 Filed: 11/14/2024 | Filing → | |
| Sale | 50,000 | $10.06 | $503K | 7,500 | 11/12/2024 Filed: 11/14/2024 | Filing → | |
| Exercise | 50,000 | $7.45 | $373K | 57,500 | 11/12/2024 Filed: 11/14/2024 | Filing → | |
| Award | 49,303 | - | - | 49,303 | 6/11/2024 Filed: 6/13/2024 | Filing → | |
| Award | 50,000 | - | - | 50,000 | 3/1/2024 Filed: 3/5/2024 | Filing → | |
Cara Therapeutics, Inc. CARA | Sale | 5,488 | $0.53 | $3K | 8,012 | 2/8/2023 Filed: 2/12/2024 | Filing → |
Cara Therapeutics, Inc. CARA | Award | 13,500 | - | - | 13,500 | 2/1/2024 Filed: 2/5/2024 | Filing → |
| Award | 51,955 | $0.00 | $0 | 51,955 | 6/6/2023 Filed: 6/8/2023 | Filing → | |
Cara Therapeutics, Inc. CARA | Award | 81,000 | $0.00 | $0 | 81,000 | 3/1/2023 Filed: 3/3/2023 | Filing → |
Cara Therapeutics, Inc. CARA | Award | 225,000 | $0.00 | $0 | 225,000 | 9/12/2022 Filed: 9/14/2022 | Filing → |
| Award | 51,204 | $0.00 | $0 | 51,204 | 6/10/2022 Filed: 6/14/2022 | Filing → | |
| Purchase | 7,500 | $6.75 | $51K | 7,500 | 5/31/2022 Filed: 6/2/2022 | Filing → | |
| Award | 35,000 | $0.00 | $0 | 35,000 | 6/29/2021 Filed: 7/1/2021 | Filing → | |
| Award | 35,000 | $0.00 | $0 | 35,000 | 6/8/2020 Filed: 6/10/2020 | Filing → | |
| Award | 35,000 | $0.00 | $0 | 35,000 | 6/10/2019 Filed: 6/11/2019 | Filing → | |
| Award | 35,000 | $0.00 | $0 | 35,000 | 7/17/2018 Filed: 7/19/2018 | Filing → | |
RIGEL PHARMACEUTICALS INC RIGL | Exercise | 100,000 | $0.00 | $0 | 75,000 | 11/3/2017 Filed: 11/7/2017 | Filing → |
RIGEL PHARMACEUTICALS INC RIGL | Sale | 100,000 | $3.90 | $390K | 0 | 11/3/2017 Filed: 11/7/2017 | Filing → |
Type
Award
Shares
90,316
Price
-
Value
-
Type
Award
Shares
67,546
Price
-
Value
-
Type
Exercise
Shares
50,000
Price
-
Value
-
Type
Sale
Shares
50,000
Price
$10.06
Value
$503K
Type
Exercise
Shares
50,000
Price
$7.45
Value
$373K
Type
Award
Shares
49,303
Price
-
Value
-
Type
Award
Shares
50,000
Price
-
Value
-
Cara Therapeutics, Inc.
CARA
Type
Sale
Shares
5,488
Price
$0.53
Value
$3K
Cara Therapeutics, Inc.
CARA
Type
Award
Shares
13,500
Price
-
Value
-
Type
Award
Shares
51,955
Price
$0.00
Value
$0
Cara Therapeutics, Inc.
CARA
Type
Award
Shares
81,000
Price
$0.00
Value
$0
Cara Therapeutics, Inc.
CARA
Type
Award
Shares
225,000
Price
$0.00
Value
$0
Type
Award
Shares
51,204
Price
$0.00
Value
$0
Type
Purchase
Shares
7,500
Price
$6.75
Value
$51K
Type
Award
Shares
35,000
Price
$0.00
Value
$0
Type
Award
Shares
35,000
Price
$0.00
Value
$0
Type
Award
Shares
35,000
Price
$0.00
Value
$0
Type
Award
Shares
35,000
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Exercise
Shares
100,000
Price
$0.00
Value
$0
RIGEL PHARMACEUTICALS INC
RIGL
Type
Sale
Shares
100,000
Price
$3.90
Value
$390K
AI Agent
Try asking...